NSC-658497 is primarily investigated for its potential in cancer research, particularly as an inhibitor targeting specific cellular pathways involved in tumor growth and proliferation. Its application is focused on understanding its mechanism of action in disrupting cancer cell survival, making it a candidate for developing novel anticancer therapies. Researchers are exploring its efficacy in preclinical studies to assess its ability to induce apoptosis or inhibit angiogenesis in various cancer types. Additionally, it is being studied for its potential to enhance the effectiveness of existing chemotherapy agents when used in combination treatments.